Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 15, 2011 (rev. 1)


The J. Craig Venter Institute has appointed Mark D. Adams as scientific director.

Adams will be responsible for directing all research projects at JCVI's Rockville, Md., and San Diego, Calif., campuses and will be based in the San Diego facility.

Adams joins JCVI from Case Western Reserve University, where he worked from 2003 to 2011 as an associate professor in the department of genetics and was also director of the Case Western Genomics Core Facility.

Prior to Case Western, Adams worked at Celera Genomics from 1998 to 2003, where he was first vice president for genome programs and then vice president of bioinformatics.

Adams joined Celera from the Institute for Genomic Research, where he worked with Venter as director of the DNA sequencing facility. He also worked with Venter as a postdoc at the National Institute of Neurological Disorders and Stroke.

He holds a BA in chemistry from Warren Wilson College and a PhD in biological chemistry from the University of Michigan.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.